Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
Interventions
RADIATION

radiation therapy

Undergo radiotherapy

DRUG

carboxyamidotriazole

Given orally

OTHER

pharmacological study

Correlative studies

Trial Locations (8)

19104

University of Pennsylavania/Abramson Cancer Center, Philadelphia

21287

Johns Hopkins University, Baltimore

27157

Wake Forest University, Winston-Salem

30322

Emory University/Winship Cancer Institute, Atlanta

33612

Moffitt Cancer Center, Tampa

35294

University of Alabama Birmingham, Birmingham

48202

Henry Ford Hospital, Detroit

78229

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00004146 - Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM | Biotech Hunter | Biotech Hunter